Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: August 2019

MissionIRNewsBreaks – Genprex, Inc. (NASDAQ: GNPX) Chairman and CEO to Present at the 4th Annual Disruptive Growth Conference

Posted on August 21, 2019 by MissionIR

Clinical-stage gene therapy company Genprex (NASDAQ: GNPX) this morning announced that its Chairman and Chief Executive Officer, Rodney Varner, is scheduled to present at the 4th Annual Disruptive Growth Conference. ReedSmith is hosting the event, which features growth companies with … Continue reading →

Posted in Genprex Inc. GNPX, MissionIRNewsBreaks | Leave a comment

MissionIRNewsBreaks – Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) Targets Billion-Dollar AR/VR Market

Posted on August 20, 2019 by MissionIR

Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT), a producer, developer and operator of popular, augmented reality, interactive, entertainment games and toys in China, is well positioned in a market that is anticipated to see continuous growth in the coming years. … Continue reading →

Posted in Blue Hat Interactive Entertainment Technology BHAT, MissionIRNewsBreaks | Leave a comment

MissionIRNewsBreaks – Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) Joint Manufacturing Partnership Opens Door to Widespread Distribution

Posted on August 20, 2019 by MissionIR

Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP), a biotechnology company and drug-delivery platform innovator, is increasing the reach of its revolutionary DehydraTECH(TM) technology that enables the rapid onset of ingested cannabis. An article discussing the company reads, “DehydraTECH is a drug-delivery … Continue reading →

Posted in Lexaria Bioscience Corp. (LXRP), MissionIRNewsBreaks | Leave a comment

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Drug-Delivery Platform Could Help Smokers Stub Cigarettes

Posted on August 20, 2019 by MissionIR

Lexaria recently announced its entry into a partnership with a tobacco giant to fund the research and development of oral nicotine delivery solutions The company received a cannabis R&D license from Health Canada LXRP also announced its receipt of four … Continue reading →

Posted in Lexaria Bioscience Corp. (LXRP) | Leave a comment

MissionIRNewsBreaks – Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) to Commence Trading on the Toronto Stock Exchange on August 22

Posted on August 20, 2019 by MissionIR

Organigram Holdings (TSX.V: OGI) (NASDAQ: OGI), the parent company of Organigram Inc., a leading licensed producer of cannabis, this morning announced that it has received final approval to list its common shares on the Toronto Stock Exchange (“TSX”). The company’s … Continue reading →

Posted in MissionIRNewsBreaks, Organigram Holdings Inc. OGI | Leave a comment

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) R&D Finds Lack of Adverse Chemical Byproducts in Manufacture of Drug Delivery Compositions

Posted on August 19, 2019 by MissionIR

Lexaria Bioscience is involved in the research and improvement of its trademarked DehydraTECH technology, which enhances the bioavailability of some legal drug substances used by consumers The technology provides a rapid-on, rapid-off effect that may be effectively used in cannabis-infused … Continue reading →

Posted in Lexaria Bioscience Corp. (LXRP) | Leave a comment

MissionIRNewsBreaks – Youngevity International Inc.’s (NASDAQ: YGYI) Khrysos Industries Enters Strategic 5-Year Supply Agreement with DJB Industries

Posted on August 19, 2019 by MissionIR

Youngevity International (NASDAQ: YGYI), a leading multi-channel lifestyle company operating in three distinct business segments, this morning announced the entry of its wholly owned subsidiary, Khrysos Industries, Inc., into a 5-year supply contract with DJB Industries Inc. to provide extraction … Continue reading →

Posted in MissionIRNewsBreaks, Youngevity International Inc. YGYI | Leave a comment

Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) Receives Media Attention following Release of Strong Results

Posted on August 19, 2019 by MissionIR

Organigram’s Q3 results marked its fourth quarter in a row of positive adjusted EBITDA* A Bloomberg article states that the company is an outlier due to its high margins and low production costs Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) … Continue reading →

Posted in Organigram Holdings Inc. OGI | Leave a comment

MissionIRNewsBreaks – Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) Aims to Modernize Classrooms in China via Strategic Partnership Agreement

Posted on August 16, 2019 by MissionIR

Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT), a producer, developer and operator of popular, augmented-reality, interactive, entertainment games and toys in China, recently entered a strategic agreement with Guangdong Family Periodicals Group. The two companies are partnering to develop innovative … Continue reading →

Posted in Blue Hat Interactive Entertainment Technology BHAT, MissionIRNewsBreaks | Leave a comment

INmune Bio Inc. (NASDAQ: INMB) Announces Continuous Advancement of Clinical Program, New Strategic Appointment

Posted on August 16, 2019 by MissionIR

The immunology company released its financial results for the second quarter of 2019 and also delivered an update on its clinical trials The phase I trial of INmune Bio’s cancer treatment INB03 has delivered promising results in terms of safety … Continue reading →

Posted in INmune Bio Inc. INMB | Leave a comment